OAD0503 | Identifying longitudinal patterns of HIV treatment (dis)engagement and re-engagement from oral histories of virologically unsuppressed adults in Uganda: a thematic trajectory analysis | Oral abstract session with live Q&A | Social and behavioural aspects and approaches to HIV |
EPC0502 | Identifying gaps in the HIV care continuum among indigenous Mayan persons living with HIV in Guatemala | E-poster | Cascades of HIV care and treatment |
EPE0983 | Identifying efficiency estimates and associated factors for HIV testing, treatment, and viral load suppression programs in 25 PEPFAR-supported countries, 2016-2021 | E-poster | Innovations in data collection, monitoring and evaluation |
EPE0952 | Identification of strategies to enhance the provision of holistic services across three community-based organizations in Seattle | E-poster | Integration of HIV services with other health and support services |
EPA0028 | Identification of SIV infected mast cells in early sites of viral rebound | E-poster | HIV pathogenesis |
EPA0053 | Identification of novel PTPN1/PTPN2 inhibitors to target latent HIV reservoirs | E-poster | Understanding and targeting persistent HIV reservoirs |
EPA0007 | Identification of a new HIV-1 BF1 intersubtype recombinant form circulating in Turkey, that has generated a secondary recombinant form with CRF56_cpx transmitted in Spain | E-poster | HIV virology |
EPA0042 | Identification and characterization of HIV-1-specific CD8+ T cells in highly HIV-1 exposed but uninfected MsM in Vietnam | E-poster | Host immune responses, vaccines and immunotherapies |
EPA0040 | Ibalizumab and CD4 domain 2 exert an allosteric effect on HIV envelope binding to CD4 domain1 | E-poster | Host immune responses, vaccines and immunotherapies |
EPE0783 | I’m Ready 5,000: effectiveness of mobile app to distribute free HIV self-tests across Canada to reach the undiagnosed with HIV | E-poster | Implementation science and scale up of HIV testing |